Recovered COVID-19 patients may need only a single vaccine dose, suggests study
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […]
» Read moreHome »
Medical implants of the future may feature reconfigurable electronic platforms that can morph in shape and size dynamically as bodies […] The amount of antibiotics entering the River Thames would need to be cut by as much as 80 per cent […] Antibiotic resistance does not spread only where and when antibiotics are used in large quantities, researchers conclude from laboratory experiments. […] Coagulation factors, which are involved in blood clotting after injury, may offer new strategies for fighting multidrug-resistant bacteria, according to […] For decades, immunologists have been trying to train the transplant recipient’s immune system to accept transplanted cells and organs without […] Researchers at LSTM have taken significant steps in understanding the way that the anti-malarial drug primaquine (PQ) works, which they […] In a review publishing July 17 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could […] A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a […] Natural products, or their close derivatives, make some of our most potent medicines, among which macrocycles with their large carbon-rich […]
Reconfigurable electronics show promise for wearable, implantable devices
80% cut in antibiotics entering Thames is needed to avoid surge in superbugs: Modelling study estimates extent of river’s exposure to antibiotic-resistant bacteria
Resistance can spread even without the use of antibiotics
Blood clotting factors may help fight multi-drug resistant superbugs
Need for anti-rejection drugs in transplant recipients
Understanding the mode of action of the primaquine: New insights into a 70 year old puzzle
Review evaluates how AI could boost the success of clinical trials
Artificial DNA can control release of active ingredients from drugs
Learning from nature’s bounty: New libraries for drug discovery
